Skip Navigation LinksHome > April 1999 - Volume 90 - Issue 4 > Is Ropivacaine Less Potent than Bupivacaine?
Editorial Views

Is Ropivacaine Less Potent than Bupivacaine?

D'Angelo, Robert MD; James, Robert L. MS, MStat

Free Access
Article Outline
Collapse Box

Author Information

This Editorial View accompanies the following article: Polley LS, Columb MO, Naughton NN, Wagner DS, van de Ven CJM: Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: Implications for therapeutic indexes. Anesthesiology 1999; 90:944‐50.
IN this issue of Anesthesiology appears the first clinical trial comparing the relative analgesic potency of epidural ropivacaine to epidural bupivacaine. [1] Both drugs are amide local anesthetics and similar in structure; however, ropivacaine is marketed as the L‐isomer, whereas bupivacaine is marketed as a racemic mixture. Because bupivacaine produces motor block and can cause cardiac arrest when large volumes are accidentally administered intravenously, ropivacaine has been investigated as a possible replacement. Indeed, evidence suggests that ropivacaine may be less cardiotoxic [2] and produces less motor block [3] than bupivacaine. Until now, these differences were attributed to the chemical properties of the local anesthetics rather than to differences in potency because it was assumed that ropivacaine and bupivacaine were equipotent. These findings, however, would be subject to reassessment if ropivacaine were 40% less potent than bupivacaine, as Polley et al. [1] suggest. This result would imply that both local anesthetics might produce similar side effects at equipotent concentrations. All to often, comparison trials are completed without full knowledge of the relative potencies or the respective dose‐response curves for any two drugs; most likely because traditional dose‐response studies are tedious, time consuming, and costly. Nevertheless, only when these variables are known can adequate comparison trials be designed. Even now that Polley et al. [1] estimate the effective dose in 50% of a population (ED50) for ropivacaine and bupivacaine, the full dose‐response curves, with respect to labor analgesia, for each remain unknown. Until the slope and shape of these dose‐response curves are known, are isolated ED50 values meaningful? Let us discuss the technique used by Polley et al. [1] to estimate the ED50 values for ropivacaine and bupivacaine and the implications of differences in potency between these two local anesthetics.
Table 1
Table 1
Image Tools
Polley et al. [1] estimate the relative potencies of epidural ropivacaine and bupivacaine by using an updown sequential allocation study design, as first described for the study of epidural/spinal agents by Columb. [4] This is an elegant, yet simple, study design that estimates the minimum local analgesic concentration (MLAC) or ED50 of any local anesthetic using a small number of patients (usually < 25/group). Up‐down studies are open label, with each subsequent patient's dose varied according to the previous patient's response. Dosing intervals are usually set at equal intervals on a log scale. This design is much more efficient at estimating the ED50 than traditional dose‐response designs because it focuses all the sampling doses in the immediate vicinity of the ED50. However, shortcomings exist (although not all apply to the article in question). The high statistical efficiency of up‐down studies are dependent on the choice of the initial drug dose and the sequential spacing between dose levels, which are somewhat arbitrarily selected by the investigators. If the initial dose tested does not approximate the ED50, initial trials are wasted in finding the vicinity of the ED50 value; and, if the spacing of incremental doses does not approximate the standard deviation of the ED50, the 95% confidence limits become biased. Unfortunately, neither good estimates of the ED50 nor its standard deviation may be available when designing a study. Additionally, up‐down studies cannot replace traditional dose‐response studies. The ED50 estimated in an up‐down study does not provide information regarding the slope or the shape of the dose‐response curve or ED95, among others. For example, although the ED50 values for two drugs may vary, it is possible the dose‐response curves overlap at higher concentrations. In fact, this may explain why ropivacaine appears to be 40% less potent than bupivacaine at ED50 concentrations but equipotent at higher concentrations. Finally, because only a few patients are enrolled in up‐down studies, it is difficult to control for confounding variables. Although six studies to date using nearly identical up‐ down designs have estimated the ED50 of epidural bupivacaine, [1,4‐8] the estimated ED50 values very considerably (Table 1). In fact, three of seven estimated ED50 values for bupivacaine are similar to the estimated ED50 for ropivacaine by Polley et al. [1] The differences in ED50 values for bupivacaine may reflect variations in patient populations or, potentially, uncontrolled variables. For example, parity was not controlled in any of these six labor pain studies. Because the duration [9] and pain intensity [10] of labor varies with parity, this variable may have contributed to this discrepancy. In fact, we recently confirmed this observation, to our chagrin, when data from 40 patients in an up‐down study at our institution estimating the ED50 of spinal sufentanil had to be discarded when significant differences in visual analog scales scores were observed between nulliparous and parous women (unpublished findings, 1996‐1997). We now only enroll nulliparous women in our up‐down studies.
Although Polley et al. [1] suggest that epidural ropivacaine is 40% less potent than epidural bupivacaine, clinical experience in treating the pain of labor at our institution does not support such a large difference in potency between ropivacaine and bupivacaine. We recently compared 0.125% ropivacaine to 0.125% bupivacaine with and without fentanyl, 2 [micro sign]g/ml, using patient‐controlled epidural analgesia (6 ml basal infusion, 5 ml on‐demand bolus, 10 min lockout, 30 ml hourly dose limit) for precise titration. [11,12] Patients self‐administered the same doses of ropivacaine and bupivacaine to produce clinically indistinguishable analgesia and patient satisfaction. These studies were adequately powered to have observed a 40% difference in potency between drugs at such clinically relevant concentrations, if it exists. Likewise, numerous studies comparing 0.2‐1.0% ropivacaine to 0.2‐0.5% bupivacaine describe equipotent analgesia between local anesthetics. However, as Polley et al. [1] suggest, the concentrated solutions used in these studies may have masked any differences in potency or may reflect overlapping at the higher end of the dose‐response curves.
Despite the limitations of up‐down studies, the ED50 values estimated by Polley et al. [1] are meaningful and may have clinical implications. By suggesting that ropivacaine is less potent than bupivacaine at the ED50, the possibility exists that differences in potency between local anesthetics also exit at other points of the dose‐response curves. Indeed, differences in potency could have accounted for differences in side effects and toxicity observed in all previous studies. Until traditional dose‐response studies thoroughly evaluate the potency of epidural ropivacaine and bupivacaine, investigators must now at least consider the potency of ropivacaine when designing comparative trials.
Robert D'Angelo, M.D.
Robert L. James, M.S., M.Stat.
Department of Anesthesiology, Section on Obstetric Anesthesia; Wake Forest University School of Medicine; Winston‐Salem, North Carolina;
Back to Top | Article Outline


1. Polley LS, Columb MO, Naughton NN, Wagner DS, van de Ven CJM: Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: Implications for therapeutic indexes. Anesthesiology 1999; 90:944-50

2. Feldman HS, Arthur GR, Covino BG: Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989; 69:794-801

3. Datta S, Camann W, Bader A, VanderBurgh L: Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology 1995; 82:1346-52

4. Columb MO, Lyons G: Determination of the minimum local analgesic concentrations of epidural bupivacaine and lidocaine in labor. Anesth Analg 1995; 81:883-7

5. Polley LS, Columb MO, Wagner DS, Naughton NN: Dose-dependent reduction of the minimal local analgesic concentration of bupivacaine by sufentanil for epidural analgesia in labor. Anesthesiology 1998; 89:626-32

6. Lyons G, Columb M, Hawthorne L, Dresner M: Extradural pain relief in labour: Bupivacaine sparing by extradural fentanyl is dose dependent. Br J Anaesth 1997; 78:493-7

7. Capogna G, Celleno D, Lyons G, Columb M, Fusco P: Minimum local analgesic concentration of extradural bupivacaine increases with progression of labour. Br J Anaesth 1998; 80:11-3

8. Capogna G, Cellano D, Lyons G, Columb M: Determination of the minimum local analgesic concentration of epidural ropivacaine in labour. Br J Anaesth 1998; 81:A506

9. Friedman EA: Labor: Clinical Evaluation and Management, 2nd Edition. New York, Appleton-Century-Crofts, 1978

10. Melzack R: The myth of painless childbirth. Pain 1984; 12:321-37

11. Owen MD, D'Angelo R, Gerancher JC, Thompson JM, Foss ML, Babb JD, Eisenach JC: 0.125% ropivacaine is similar to 0.125% bupivacaine for labor analgesia using patient-controlled epidural infusion. Anesth Analg 1998; 86:527-31

12. Meister G, Owen M, D'Angelo R, Gaver R: Comparison of 0.125% ropivacaine + fentanyl 2 [micro sign]g/ml and 0.125% bupivacaine + fentanyl 2 [micro sign]g/ml in laboring patients (abstract). Anesthesiology 1998; 89(3A):A1023.

Cited By:

This article has been cited 34 time(s).

Regional Anesthesia and Pain Medicine
Does local anesthetic stereoselectivity or structure predict myocardial depression in anesthetized canines?
Groban, L; Deal, DD; Vernon, JC; James, RL; Butterworth, J
Regional Anesthesia and Pain Medicine, 27(5): 460-468.
Anesthesia and Analgesia
Local anesthetics and mode of delivery: Bupivacaine versus ropivacaine versus levobupivacaine
Beilin, Y; Guinn, NR; Bernstein, HH; Zahn, J; Hossain, S; Bodian, CA
Anesthesia and Analgesia, 105(3): 756-763.
Anesthesia and Analgesia
Acute pain management revisited
Rowlingson, JC
Anesthesia and Analgesia, 94(3): 92-99.

Anesthesia and Analgesia
The relative motor blocking potencies of epidural bupivacaine and ropivacaine in labor
Lacassie, HJ; Columb, MO; Lacassie, HP; Lantadilla, RA
Anesthesia and Analgesia, 95(1): 204-208.
Anesthesia and Analgesia
The effect of clonidine on the minimum local analgesic concentration of epidural ropivacaine during labor
Aveline, C; El Metaoua, S; Masmoudi, A; Boelle, PY; Bonnet, F
Anesthesia and Analgesia, 95(3): 735-740.
Anaesthetic agents for advanced regional anaesthesia - A North American perspective
Buckenmaier, CC; Bleckner, LL
Drugs, 65(6): 745-759.

International Journal of Obstetric Anesthesia
Patient-controlled epidural analgesia for labor pain: effect on labor, delivery and neonatal outcome of 0.125% bupivacaine vs 0.2% ropivacaine
Evron, S; Glezerman, M; Sadan, O; Boaz, M; Ezri, T
International Journal of Obstetric Anesthesia, 13(1): 5-10.
Anesthesia and Analgesia
A comparison of epidural bupivacaine, levobupivacaine, and ropivacaine on postoperative analgesia and motor blockade
De Negri, P; Ivani, G; Tirri, T; Modano, P; Reato, C; Eksborg, S; Lonnqvist, PA
Anesthesia and Analgesia, 99(1): 45-48.
Anesthesia and Analgesia
The effects of age on the median effective concentration of ropivacaine for motor blockade after epidural anesthesia with ropivacaine
Li, YH; Zhu, SM; Bao, FP; Xu, JH; Yan, X; Jin, XD
Anesthesia and Analgesia, 102(6): 1847-1850.
Regional Anesthesia and Pain Medicine
Regional anesthesia with ropivacaine
Whiteside, J
Regional Anesthesia and Pain Medicine, 25(6): 659.

Anesthesia and Analgesia
A comparison of duration of analgesia of intrathecal 2.5 mg of bupivacaine, ropivacaine, and levobupivacaine in combined spinal epidural analgesia for patients in labor
Lim, Y; Ocampo, CE; Sia, AT
Anesthesia and Analgesia, 98(1): 235-239.
Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie
0.2% ropivacaine and levobupivacaine provide equally effective epidural labour analgesia
Supandji, M; Sia, ATH; Ocampo, CE
Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie, 51(9): 918-922.

Anesthesia and Analgesia
Update on acute pain management
Rowlingson, JC
Anesthesia and Analgesia, (): 95-106.

Anesthesia and Analgesia
Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats
Ohmura, S; Kawada, M; Ohta, T; Yamamoto, K; Kobayashi, T
Anesthesia and Analgesia, 93(3): 743-748.

British Journal of Anaesthesia
A comparison of 0.0625% ropivacaine or bupivacaine combined with fentanyl 2 mu g ml(-1) administered by patient-controlled epidural analgesia in labour
Neal, SM; Hiscock, R; Anderson, M; Ross, A; Solly, M
British Journal of Anaesthesia, 87(4): 658P-659P.

Anesthesia and Analgesia
Acute pain management revisited
Rowlingson, JC
Anesthesia and Analgesia, 96(3): 87-95.

Anesthesia and Analgesia
The relative toxicity of amitriptyline, bupivacaine, and levobupivacaine administered as rapid infusions in rats
Srinivasa, V; Gerner, P; Haderer, A; Abdi, S; Jarolim, P; Wang, GK
Anesthesia and Analgesia, 97(1): 91-95.
Regional Anesthesia and Pain Medicine
Pain relief by wound infiltration with bupivacaine or high-dose ropivacaine after inguinal hernia repair
Pettersson, N; Berggren, P; Larsson, M; Westman, B; Hahn, RG
Regional Anesthesia and Pain Medicine, 24(6): 569-575.

Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie
Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl
Berti, M; Fanelli, G; Casati, A; Albertin, A; Palmisano, S; Deni, F; Perotti, V; Torri, G
Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie, 47(1): 27-32.

Acta Anaesthesiologica Scandinavica
New local anaesthetics - how much is improved safety worth?
Wildsmith, JAW
Acta Anaesthesiologica Scandinavica, 45(5): 652-653.

Regional Anesthesia and Pain Medicine
Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model
Groban, L
Regional Anesthesia and Pain Medicine, 28(1): 3-11.
Minimum local analgesic dose of plain ropivacaine vs. ropivacaine combined with sufentanil during epidural analgesia for labour
Palm, S; Gertzen, W; Ledowski, T; Gleim, M; Wulf, H
Anaesthesia, 56(6): 526-529.

International Journal of Obstetric Anesthesia
Toxicity and safety of epidural local anaesthetics
Lyons, G; Reynolds, F
International Journal of Obstetric Anesthesia, 10(4): 259-262.

International Journal of Obstetric Anesthesia
Up-down studies: responding to dosing!
Columb, MO; D'Angelo, R
International Journal of Obstetric Anesthesia, 15(2): 129-136.
Analgesia during labour: from tabu to evidence-based medicine
Schneider, MC
Anaesthesist, 51(): 959-+.
Drug Safety
Benefit-risk assessment of ropivacaine in the management of postoperative pain
Zink, W; Graf, BM
Drug Safety, 27(): 1093-1114.

CNS Drugs
Neuraxial drug administration - A review of treatment options for anaesthesia and analgesia
Schug, SA; Saunders, D; Kurowski, I; Paech, MJ
CNS Drugs, 20(): 917-933.

Regional Anesthesia and Pain Medicine
Comparison of racemic bupivacaine, ropivacaine, and levo-bupivacaine for pediatric caudal anesthesia: Effects on postoperative analgesia and motor block
Ivani, G; DeNegri, P; Conio, A; Grossetti, R; Vitale, P; Vercellino, C; Gagliardi, F; Eksborg, S; Lonnqvist, PA
Regional Anesthesia and Pain Medicine, 27(2): 157-161.
Anesthesia and Analgesia
A comparison of three different concentrations of levobupivacaine for caudal block in children
Ivani, G; De Negri, P; Lonnqvist, PA; Eksborg, S; Mossetti, V; Grossetti, R; Italiano, S; Rosso, F; Tonetti, F; Codipietro, L
Anesthesia and Analgesia, 97(2): 368-371.
Relative Potencies of Ropivacaine and Bupivacaine
Wildsmith, J
Anesthesiology, 92(1): 283.

PDF (216)
A Comparison of Median Effective Doses of Intrathecal Levobupivacaine and Ropivacaine for Labor Analgesia
Sia, AT; Goy, RW; Lim, Y; Ocampo, CE
Anesthesiology, 102(3): 651-656.

PDF (218)
Determination of the Full Dose–Response Relation of Intrathecal Bupivacaine, Levobupivacaine, and Ropivacaine, Combined with Sufentanil, for Labor Analgesia
Van de Velde, M; Dreelinck, R; Dubois, J; Kumar, A; Deprest, J; Lewi, L; Vandermeersch, E
Anesthesiology, 106(1): 149-156.

PDF (582)
European Journal of Anaesthesiology (EJA)
A multicentre trial comparing different concentrations of ropivacaine plus sufentanil with bupivacaine plus sufentanil for patient-controlled epidural analgesia in labour
Marcus, MA; Gogarten, W; Van de Velde, M; Soetens, F; Van Aken, H; Brodner, G; Gramke, H; Soetens, M
European Journal of Anaesthesiology (EJA), 21(1): 38-45.

PDF (1066)
Sensory Assessment of Regional Analgesia in Humans: A Review of Methods and Applications
Curatolo, M; Petersen-Felix, S; Arendt-Nielsen, L
Anesthesiology, 93(6): 1517-1530.

PDF (218)
Back to Top | Article Outline
Dose‐response; epidural; labor analgesia; up‐down study.

© 1999 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.

Article Tools



Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.